Moderna announced first participant dosed in NIH-led phase 1 study of mRNA vaccine against novel Coronavirus
On Mar. 16, 2020, Moderna announced that the first participant had been dosed in the Phase 1 study…
-
-
NIH Reported First Known Employee with COVID-19 Infection
On Mar. 15, 2020, the National Institutes of Health (NIH) informed its staff that it had its first…
-
Biotechnology | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Vaccine | WHO
National Emergency declared in U.S. for novel Coronavirus disease outbreak
On Mar. 13, 2020, declared a COVID-related emergency under Section 501(b) of the Stafford Act [18]. Under the…
-
Biotechnology | Medicine | NIH | Therapeutics
NIH researchers discovered tooth-enamel protein in eyes with dry AMD
On Mar. 13, 2020, researchers at the National Eye Institute (NEI) reported finding a protein that normally deposits…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics
Emory University among U.S. sites to host clinical trial for COVID-19 treatment
On Mar. 12, 2020, Emory University announced it was participating in a National Institutes of Health (NIH) sponsored…
-
Vir Biotec announced research collaboration with NIH Vaccine Research Center on antibodies against coronaviruses
On Mar. 11, 2020, Vir Biotech announced a research collaboration agreement with the NIH to advance characterization and…
-
Biotechnology | HIV | NIH | Therapeutics
Drug-delivery technology leads to sustained HIV antibody production in NIH study
On Mar. 9, 2020, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the…
-
Winship Cancer Institute’s multiple myeloma team awarded $5 million grant from the Leukemia & Lymphoma Society
On Mar. 9, 2020, Winship Cancer Institute’s multiple myeloma team was awarded a $5 million grant from The…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | U.S. Congress
Innovation Pharma Brilacidin received by US Regional Biocontainment Lab for testing against COVID-19
On Mar. 9, 2020, Innovation Pharmaceuticals announced it was notified by one of the 12 Regional Biocontainment Labs…
-
$100 million investment helped hospitals across Alberta upgrade operating rooms
On Mar. 5, 2020, a $100 million government investment was announced that helped hospitals across the province upgrade…
-
Neurology | NIH | Therapeutics
Scientists monitored brains replaying memories in real time
On Mar. 5, 2020, in a study of epilepsy patients, researchers at the National Institutes of Health (NIH)…
-
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
Testing with combined biopsy method improves prostate cancer diagnosis in NCI study
On Mar. 4, 2020, a method of testing for prostate cancer developed at the National Cancer Institute (NCI)…
-
CDC | COVID-19 | Diagnostics | NIH | Therapeutics | Vaccine
COVID-19 a reminder of the challenge of emerging infectious diseases
On Feb. 28, 2020, commentary appeared in The New England Journal of Medicine that discussed the emergence and…
-
NIH announced $1 million prize competition to target global disease diagnostics
On Feb. 25, 2020, the U. S. National Institutes of Health (NIH) announced it had launched a $1…
-
NIH clinical trial of remdesivir to treat COVID-19 began for adults with coronavirus disease
On Feb. 25, 2020, the National Institutes of Health (NIH) announced that a randomized, controlled clinical trial to…
-
Moderna shipped mRNA vaccine against novel Coronavirus (mRNA-1273) for phase 1 study
On Feb. 24, 2020, Moderna announced it had released the first batch of mRNA-1273, the Company’s vaccine against…
-
FDA | NIH | U.S. Congress
Federal Judge ruled missing clinical trial data must be made public
On Feb. 22, 2020, a federal judge from the Southern District of New York ruled drug companies, device…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Therapeutics | Vaccine
NIH scientists identified atomic structure of novel Coronavirus protein
On Feb. 19, 2020, NIAID scientists working with investigators from the University of Texas at Austin identified the…
-
Medigen Vaccine Biologics and NIH collaborated to develop COVID-19 vaccine
On Feb. 16, 2020, Medigen Vaccine Biologics (MVB) and the National Institutes of Health (NIH) announced they had…
-
Remdesivir prevented MERS coronavirus disease in monkeys
On Feb. 13, 2020, National Institutes of Health (NIH) scientists announced that the experimental antiviral remdesivir successfully prevented…
-
U.S. Department of Health and Human Services announced COVID-19 Public Health Emergency
On Jan. 31, 2020, the U.S. Departments of Health and Human Services announced that as a result of…
-
Mammoth Biosciences secured contract from NIH to scale high-throughput CRISPR SARS-CoV-2 diagnostic platform
On Jan. 31, 2020, Mammoth Biosciences announced the company had received a contract from the National Institutes of…
-
NIH officials discussed novel coronavirus that recently emerged in China
On Jan. 23, 2020, the new cluster of viral pneumonia cases originating in Wuhan, China, marked the third…
-
Moderna announced funding award from CEPI to accelerate development of mRNA vaccine against novel Coronavirus
On Jan. 23, 2020, Moderna announced a new collaboration to develop an mRNA vaccine against the novel coronavirus…
-
The Vanderbilt Vaccine Research Program received NIH grant to continue work as Vaccine and Treatment Evaluation
On Jan. 23, 2020, the Vanderbilt Vaccine Research Program (VVRP) received a grant from the National Institutes of…
-
Secretary Azar declared Public Health Emergency for the U.S. for 2019 Novel Coronavirus
On Jan 31, 2020, Health and Human Services Secretary Alex M. Azar II declared a public health emergency…
-
Biotechnology | CDC | FDA | NIH | Non-Profit Research | Pharmaceutical | Vaccine
CDC published updated ACIP recommendations for use of PCV13 and PPSV23 pneumococcal vaccines for adults age 65 and older
On Nov. 22, 2019, the Centers for Disease Control and Prevention”s (CDC) Advisory Committee on Immunization Practices (ACIP)…
-
Penn Medicine researchers received $97 million grant from the NIH to study traumatic brain injuries and neurodegeneration
On Oct. 24, 2019, Penn Medicine researchers received $9.7 million grant from the NIH to study traumatic brain…
-
UPenn researchers received a $20 million NIH grant to develop a critical tool for imaging Parkinson’s and other diseases
On Oct. 10, 2019, University of Pennsylvania (UPenn) researchers announced they had received a $20 million National Institutes…
-
Penn Medicine received $22 million from NIH HEAL Initiative to combat the national opioid crisis
On Oct. 4, 2019, Penn Medicine announced they had received $22 Million from National Institutes of Health’s (NIH)…
